Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.

<h4>Purpose</h4>This study aims to analyse the efficacy of GBE administration in patients with glaucoma and healthy volunteers.<h4>Methods</h4>This systematic review was performed according to the PRISMA 2020 guidelines. All clinical studies investigating the efficacy of GBE...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Prinz, Verena Prokosch, Xiaosha Wang, Yuan Feng, Peter Walter, Matthias Fuest, Filippo Migliorini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314644
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849311994284343296
author Julia Prinz
Verena Prokosch
Xiaosha Wang
Yuan Feng
Peter Walter
Matthias Fuest
Filippo Migliorini
author_facet Julia Prinz
Verena Prokosch
Xiaosha Wang
Yuan Feng
Peter Walter
Matthias Fuest
Filippo Migliorini
author_sort Julia Prinz
collection DOAJ
description <h4>Purpose</h4>This study aims to analyse the efficacy of GBE administration in patients with glaucoma and healthy volunteers.<h4>Methods</h4>This systematic review was performed according to the PRISMA 2020 guidelines. All clinical studies investigating the efficacy of GBE administration on the intraocular pressure (IOP), the corrected pattern standard deviation (CPSD) and the mean deviation of visual field testing, and heart rate were considered. The weighted mean difference (MD) effect measure, 95% confidence interval (CI), and t-test were used for continuous variables.<h4>Results</h4>Data from 8 studies, including 428 patients, were retrieved. The mean age of all patients was 51.1 ± 15.5 years. The median follow-up was 3.7 (IQR 9.4) months. The administration of GBE was not associated with an improvement in IOP (MD -1.5; 95%CI -7.1 to 9.6; P = 0.5), mean deviation (MD 0.7; 95%CI -9.4 to 8.2; P = 0.8), CPSD (MD -1.6; 95%CI -3.8 to 6.9; P = 0.5), or heart rate (MD -2.5; 95%CI -11.5 to 16.5; P = 0.4) from baseline to the last follow-up. There was no difference between GBE versus the control group in IOP (MD 1.1; 95%CI -5.7 to 3.5; P = 0.4), mean deviation (MD -0.4; 95%CI -9.1 to 9.9; P = 0.9), CPSD (MD 0.3; 95%CI -6.8 to 6.2; P = 0.9), and heart rate (MD -1.3; 95%CI -15.1 to 17.7; P = 0.8) at the last follow-up.<h4>Conclusion</h4>Currently, the evidence is not sufficient to conclude that GBE affects IOP, mean deviation, CPSD, or heart rate in glaucoma patients and healthy volunteers. These conclusions must be interpreted with caution given the limitations of the reviewed studies, particularly the follow-up time of the included studies.
format Article
id doaj-art-13af47af3b0b41caacbc662f2894a0f7
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-13af47af3b0b41caacbc662f2894a0f72025-08-20T03:53:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031464410.1371/journal.pone.0314644Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.Julia PrinzVerena ProkoschXiaosha WangYuan FengPeter WalterMatthias FuestFilippo Migliorini<h4>Purpose</h4>This study aims to analyse the efficacy of GBE administration in patients with glaucoma and healthy volunteers.<h4>Methods</h4>This systematic review was performed according to the PRISMA 2020 guidelines. All clinical studies investigating the efficacy of GBE administration on the intraocular pressure (IOP), the corrected pattern standard deviation (CPSD) and the mean deviation of visual field testing, and heart rate were considered. The weighted mean difference (MD) effect measure, 95% confidence interval (CI), and t-test were used for continuous variables.<h4>Results</h4>Data from 8 studies, including 428 patients, were retrieved. The mean age of all patients was 51.1 ± 15.5 years. The median follow-up was 3.7 (IQR 9.4) months. The administration of GBE was not associated with an improvement in IOP (MD -1.5; 95%CI -7.1 to 9.6; P = 0.5), mean deviation (MD 0.7; 95%CI -9.4 to 8.2; P = 0.8), CPSD (MD -1.6; 95%CI -3.8 to 6.9; P = 0.5), or heart rate (MD -2.5; 95%CI -11.5 to 16.5; P = 0.4) from baseline to the last follow-up. There was no difference between GBE versus the control group in IOP (MD 1.1; 95%CI -5.7 to 3.5; P = 0.4), mean deviation (MD -0.4; 95%CI -9.1 to 9.9; P = 0.9), CPSD (MD 0.3; 95%CI -6.8 to 6.2; P = 0.9), and heart rate (MD -1.3; 95%CI -15.1 to 17.7; P = 0.8) at the last follow-up.<h4>Conclusion</h4>Currently, the evidence is not sufficient to conclude that GBE affects IOP, mean deviation, CPSD, or heart rate in glaucoma patients and healthy volunteers. These conclusions must be interpreted with caution given the limitations of the reviewed studies, particularly the follow-up time of the included studies.https://doi.org/10.1371/journal.pone.0314644
spellingShingle Julia Prinz
Verena Prokosch
Xiaosha Wang
Yuan Feng
Peter Walter
Matthias Fuest
Filippo Migliorini
Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
PLoS ONE
title Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
title_full Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
title_fullStr Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
title_full_unstemmed Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
title_short Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review.
title_sort efficacy of ginkgo biloba on parameters in glaucoma a systematic review
url https://doi.org/10.1371/journal.pone.0314644
work_keys_str_mv AT juliaprinz efficacyofginkgobilobaonparametersinglaucomaasystematicreview
AT verenaprokosch efficacyofginkgobilobaonparametersinglaucomaasystematicreview
AT xiaoshawang efficacyofginkgobilobaonparametersinglaucomaasystematicreview
AT yuanfeng efficacyofginkgobilobaonparametersinglaucomaasystematicreview
AT peterwalter efficacyofginkgobilobaonparametersinglaucomaasystematicreview
AT matthiasfuest efficacyofginkgobilobaonparametersinglaucomaasystematicreview
AT filippomigliorini efficacyofginkgobilobaonparametersinglaucomaasystematicreview